Orlando, FL – According to filings with the U.S. Securities and Exchange Commission, Diverse Biotech is raising $9 Million in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Stella Vnook played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Diverse Biotech

Cannabinoids have exciting potential as tomorrow’s greatest medicines. Today, however, asking the right questions about how and why they work is critical. Diverse Pharma is working to understand the potential of these compounds by uncovering the mechanisms by which they work, learning how they can be used safely and effectively, and identifying the right combinations to treat the illnesses that affect us most. We are committed to being the global leader in cannabinoid R&D so that these treatments become a reality.

To learn more about Diverse Biotech, visit http://diversebiotech.com/

Contact:
Stella Vnook, Chief Executive Officer
407-776-9217
https://www.linkedin.com/in/vnook/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved